Summary
In order to study the clinical significance of cholylglycine (CG), CG in both fasting levels and after oral loading of 300 mg ursodeoxycholic acid (UDCA) were determined by radioimmunoassay in 313 patients with various liver diseases. Elevated fasting CG levels were found in 66.6% of patients with acute hepatitis (AH), 34.8% chronic inactive hepatitis (CIH), 79.3% chronic active hepatitis (CAH), 97.1% liver cirrhosis (LC), 94.7% hepatocellular carcinoma (HCC), and 80% of gall stone (GS). Changes of fasting CG during the course of AH were found to be parallel with values of transaminases. On oral loading of UDCA, different CG responses were found in CIH and CAH, and in compensated and decompensated LC. From these results we concluded that the determinations of serum CG gave additional informations of various liver diseases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hino K, et al: A comparative study of serum bile acid levels (TBA, CG) in liver disease—Difference between fasting and UDCA oral loading. Acta Hepatologica Jpn 22: 2197, 1981
Demers LM, Hepner GW: Levels of immunoreactive glycine conjugated bile acids in health and hepatobiliary disease. Am J Clin Pathol 66: 831, 1976
Korman MG, et al: Serum bile acids in chronic active liver disease. N Engl J Med 290: 1399, 1974
Tanaka N, et al: Clinical significance of determination of serum bile acid in liver disease. Acta Hepatologica Jpn 22: 785, 1981
Oshiumi Y, et al: Clinical significance of serum bile acid radioimmunoassay in hepatobiliary diseases — With special reference to the CG/SLCG ratio. Radioisotopes 28:630, 1979
Samuelson K, et al: Evaluation of fasting serum bile acid concentration in patients with liver and gastrointestinal disorders. Scan J Gastroenterol 148: 225, 1981
Morita T, et al: Clinical significance of serum bile acid measurement in liver diseases. Gastroenterologia Jpn 13:491, 1978
Angelico M, et al: Fasting and postprandial serum bile acids as a screening test for hepatocellular disease. Am J Dig Dis 22: 941, 1977
Jones MB, Gitnick GL: Clinical application of serum bile acid radioimmunoassays in differentiating asymptomatic chronic active hepatitis from chronic persistent hepatitis. Gastroenterol 76: 1162, 1979
Jones MB, et al: Clinical value of serum bile acid levels in chronic hepatitis. Digest Dis Sci 26: 978, 1981
Mayes PA: Digestion and absorption from the gastrointestinal tract: The Bile, in “Review of physiological chemistry” by Harper HA. Lange medical publications, California, 1979, p 250
Mashige F, et al: A simple and sensitive assay of total serum bile acids. Clin Chim Acta 70: 197, 1976
Larusso NF, et al: Dynamics of the enterohepatic circulation of bile acids: Postprandial serum concentrations of conjugates of cholic acid in health, cholecystectomized patients, and patients with bile acid malabsorption. N Engl J Med 291: 689, 1974
Akamatsu K, et al: A close examination of an enzymefluorometric method of determination on serum bile acid level and its alteration in liver diseases. Jpn J Gastroenterol 74: 340, 1976
Tobiasson P, et al: Serum bile acids in acute hepatitis. Scand J Gastroenterol 16: 145, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tanggo, Y., Fujiyama, S., Kin, F. et al. Clinical usefulness of serum cholylglycine determination in various liver diseases. Gastroenterol Jpn 17, 447–452 (1982). https://doi.org/10.1007/BF02774722
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02774722